Results 121 to 130 of about 12,502 (244)

Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: a meta-analysis

open access: yesChinese Medical Journal, 2019
. Background:. Previous studies on whether or not levosimendan improved the prognosis of patients with sepsis and septic shock have been inconsistent. We aimed to provide an updated analysis of the therapeutic value of levosimendan in adult patients with
Fang Feng   +6 more
doaj   +1 more source

A simple prognostic index in acute heart failure [PDF]

open access: yes, 2018
Background Rapid effective triage is integral to emergency care in patients hospitalized for heart failure, to guide the type and intensity of therapy.
Cristina MOLLICA   +3 more
core   +1 more source

Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week. [PDF]

open access: yes, 2019
The term "inotrope" is familiar and intimately connected with pharmaceuticals clinically used for treatment of low cardiac output with cardiogenic shock.
Adams, KF   +7 more
core   +2 more sources

SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?

open access: yes
European Journal of Clinical Investigation, Volume 55, Issue 11, November 2025.
Flavio Tangianu   +3 more
wiley   +1 more source

eComment. Consider trying levosimendan [PDF]

open access: yesInteractive CardioVascular and Thoracic Surgery, 2013
Levosimendan is a well established drug used nowadays routinely for the treatment of heart failure both in cardiology [1] as well as in cardiac surgery [2] despite the relatively high costs of administration [3] and the few, one must admit, adverse effects [4]. The review article by Angadi et al.
openaire   +2 more sources

Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? [PDF]

open access: yes, 2018
Aims: Changes in systolic blood pressure (SBP) during an admission for acute heart failure (AHF), especially those leading to hypotension, have been suggested to increase the risk for adverse outcomes.
Bourge, Robert C.   +16 more
core   +3 more sources

Muscle Fatigue from the Perspective of a Single Crossbridge [PDF]

open access: yes, 2016
The repeated intense stimulation of skeletal muscle rapidly decreases its force- and motion-generating capacity. This type of fatigue can be temporally correlated with the accumulation of metabolic by-products, including phosphate (Pi) and protons (H ...
Debold, Edward Patrick   +3 more
core   +1 more source

Levosimendan as rescue therapy in low output syndrome after cardiac surgery: effects and predictors of outcome

open access: yesJournal of International Medical Research, 2019
Objectives Calcium sensitizers have been shown to improve outcomes in patients with low cardiac output syndrome (LCOS) after cardiac surgery. We assessed the effects of levosimendan on LCOS in cardiac surgical patients to identify outcome predictors ...
Andres Beiras-Fernandez   +6 more
doaj   +1 more source

Transdermal delivery of levosimendan

open access: yesEuropean Journal of Pharmaceutical Sciences, 2000
The aim of this study was to determine if transdermal penetration of levosimendan, a novel positive inotropic drug, could be enhanced and controlled by formulation modifications. Penetration of levosimendan across human epidermis in vitro was determined using abdominal excised skin and diffusion cells.
R, Valjakka-Koskela   +6 more
openaire   +2 more sources

Manejo del bajo gasto cardíaco en el posoperatorio cardiovascular pediátrico [PDF]

open access: yes, 2010
Fil: Grzona, María Estela. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas.
Grzona, María Estela
core  

Home - About - Disclaimer - Privacy